Phio Pharmaceuticals Corp - ESG Rating & Company Profile powered by AI
This analysis of Phio Pharmaceuticals Corp incorporates data from across the web and also from public documents by Phio Pharmaceuticals Corp. If you work at Phio Pharmaceuticals Corp and you wish to use your ESG rating, please get in touch. This Disclosure rating includes 17 UN SDGs including: 'Zero Hunger', 'Reduced Inequalities' and 'Partnerships for the Goals'.
Phio Pharmaceuticals Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.6; made up of an environmental score of 8.0, social score of 3.2 and governance score of 2.7.
4.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1156 | Vectus Biosystems Ltd | 4.7 | High |
| 1156 | Zynerba Pharmaceuticals Inc | 4.7 | High |
| 1199 | Phio Pharmaceuticals Corp | 4.6 | High |
| 1199 | Allergan Inc | 4.6 | High |
| 1199 | AroCell AB (publ) | 4.6 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Phio Pharmaceuticals Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp report the average age of the workforce?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose cybersecurity risks?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp offer flexible work?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp conduct supply chain audits?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Phio Pharmaceuticals Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose water use targets?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid Phio Pharmaceuticals Corp have a product recall in the last two years?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose incidents of discrimination?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Phio Pharmaceuticals Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose parental leave metrics?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Phio Pharmaceuticals Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose its waste policy?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp report according to TCFD requirements?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose energy use targets?
Sign up for free to unlockDoes Phio Pharmaceuticals Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Phio Pharmaceuticals Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Phio Pharmaceuticals Corp
These potential risks are based on the size, segment and geographies of the company.
Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on targeting tumor and immune cells by regulating genes of the immune system. The company develops PH-762 that activates immune cells to recognize and kill cancer cells by reducing the expression of the checkpoint protein PD-1 for immunotherapy in adoptive cell transfer (ACT); PH-894 that silences the epigenetic protein BRD4, which is an intracellular regulator of gene expression for use in ACT; and PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for use in ACT. It has collaborations with AgonOx Inc. on clinical development of novel T cell-based cancer immunotherapies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is headquartered in Marlborough, Massachusetts.